Guardant Health Inc (GH) Q3 2024 Earnings Call Highlights: Record Revenue Growth...

Published on 6 Nov 2024 on GuruFocus.com · via Yahoo Finance

Total Revenue: $191.5 million, a 34% increase year-over-year. Precision Oncology Revenue: $180.6...

Read the rest of the article

Start tracking your investments with Statfolio

On Thursday, Cathie Wood-led Ark Invest made significant trades, with Palantir Technologies Inc. ...

Benzinga 8 Nov 2024

Total Revenue: $191.5 million, a 34% increase year-over-year. Precision Oncology Revenue: $180.6...

GuruFocus.com · via Yahoo Finance 6 Nov 2024

Overview of the Recent Transaction On October 2, 2024, Deep Track Capital, LP (Trades, Portfolio)...

GuruFocus.com · via Yahoo Finance 11 Oct 2024

A blood test to screen for colorectal cancer is one step closer to receiving approval from the U....

ABC News 25 May 2024

Stocks that are trading heavily or have substantial price changes on Friday: Workday,...

San Antonio Express-News 25 May 2024

Shares of Guardant Health Inc. closed Friday more than 13% higher day-over-day, after the Palo Al...

The Business Journals 25 May 2024

Key Insights Guardant Health's estimated fair value is US$39.63 based on 2 Stage Free Cash Flow t...

Simply Wall St. via Yahoo Finance 12 May 2024

Revenue: Reached $168.5 million in Q1 2024, a 31% increase year-over-year, surpassing estimates o...

GuruFocus.com via Yahoo Finance 12 May 2024

Guardant Health, Inc. (NASDAQ:GH) Q1 2024 Earnings Call Transcript May 10, 2024 Guardant Health, ...

Insider Monkey via Yahoo Finance 12 May 2024

In this article, we will be taking a look at the 21 countries that have the highest rates of canc...

Insider Monkey via Yahoo Finance 28 Feb 2024